Yuanli Chemical Group Co.,Ltd. (SHA:603217)
China · Delayed Price · Currency is CNY 29.83
-1.02 (-3.31%)
May 7, 2026, 3:00 PM CST
Yuanli Chemical Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 2,177 | 2,178 | 2,149 | 2,664 | 2,334 |
Other Revenue | - | 41.96 | 31.91 | 19.26 | 9.68 |
| 2,177 | 2,220 | 2,181 | 2,683 | 2,343 | |
Revenue Growth (YoY) | -1.92% | 1.75% | -18.70% | 14.49% | 91.77% |
Cost of Revenue | 1,802 | 1,846 | 1,785 | 1,983 | 1,788 |
Gross Profit | 375.46 | 373.29 | 396.25 | 700.08 | 555.26 |
Selling, General & Admin | 96.33 | 87.46 | 82.96 | 98.15 | 58.4 |
Research & Development | 89.5 | 94.15 | 91.24 | 115.3 | 87.98 |
Other Operating Expenses | -2.23 | -2.9 | -1.11 | 11.54 | 10.28 |
Operating Expenses | 183.6 | 179.45 | 172.2 | 225.15 | 159.19 |
Operating Income | 191.86 | 193.84 | 224.05 | 474.94 | 396.08 |
Interest Expense | - | -2.1 | -0.03 | -0.01 | -0.02 |
Interest & Investment Income | - | 43.04 | 48.21 | 46.56 | 36.83 |
Earnings From Equity Investments | 6.87 | - | - | - | - |
Currency Exchange Gain (Loss) | - | 5.52 | 4.2 | 9.86 | -7.48 |
Other Non Operating Income (Expenses) | 25.9 | -1.37 | -1.72 | -0.33 | -0.86 |
EBT Excluding Unusual Items | 224.63 | 238.93 | 274.71 | 531.02 | 424.53 |
Gain (Loss) on Sale of Investments | 1.03 | - | 6.42 | 3.34 | 1.99 |
Gain (Loss) on Sale of Assets | 0.01 | 0.03 | 0.01 | -2.54 | -6.13 |
Asset Writedown | -9.58 | - | -0.01 | - | -8.7 |
Other Unusual Items | - | 0.86 | 19.6 | 4.52 | 9.52 |
Pretax Income | 216.09 | 239.82 | 300.73 | 536.59 | 421.37 |
Income Tax Expense | 22.97 | 32.69 | 51.05 | 67.26 | 61.26 |
Net Income | 193.12 | 207.13 | 249.68 | 469.33 | 360.11 |
Net Income to Common | 193.12 | 207.13 | 249.68 | 469.33 | 360.11 |
Net Income Growth | -6.76% | -17.04% | -46.80% | 30.33% | 128.22% |
Shares Outstanding (Basic) | 208 | 205 | 206 | 164 | 203 |
Shares Outstanding (Diluted) | 208 | 205 | 206 | 164 | 203 |
Shares Change (YoY) | 1.26% | -0.61% | 25.74% | -19.34% | -0.07% |
EPS (Basic) | 0.93 | 1.01 | 1.21 | 2.86 | 1.77 |
EPS (Diluted) | 0.93 | 1.01 | 1.21 | 2.86 | 1.77 |
EPS Growth | -7.92% | -16.53% | -57.69% | 61.58% | 128.39% |
Free Cash Flow | -107.64 | -51.38 | -45.15 | 376.46 | 39.06 |
Free Cash Flow Per Share | -0.52 | -0.25 | -0.22 | 2.29 | 0.19 |
Dividend Per Share | - | 0.350 | 0.400 | 0.500 | 0.500 |
Dividend Growth | - | -12.50% | -20.00% | - | 110.53% |
Gross Margin | 17.25% | 16.82% | 18.17% | 26.09% | 23.69% |
Operating Margin | 8.81% | 8.73% | 10.27% | 17.70% | 16.90% |
Profit Margin | 8.87% | 9.33% | 11.45% | 17.49% | 15.37% |
Free Cash Flow Margin | -4.94% | -2.31% | -2.07% | 14.03% | 1.67% |
EBITDA | 310.11 | 291.98 | 319.79 | 556.81 | 484.31 |
EBITDA Margin | 14.24% | 13.15% | 14.66% | 20.75% | 20.67% |
D&A For EBITDA | 118.25 | 98.14 | 95.74 | 81.88 | 88.24 |
EBIT | 191.86 | 193.84 | 224.05 | 474.94 | 396.08 |
EBIT Margin | 8.81% | 8.73% | 10.27% | 17.70% | 16.90% |
Effective Tax Rate | 10.63% | 13.63% | 16.97% | 12.53% | 14.54% |
Revenue as Reported | - | 2,220 | 2,181 | 2,683 | 2,343 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.